New JN.1 COVID vaccine trial aims to shield High-Risk groups
NCT ID NCT07079670
First seen Feb 21, 2026 · Last updated May 19, 2026 · Updated 16 times
Summary
This study tests a new vaccine designed to protect against the Omicron JN.1 variant of COVID-19. About 120 adults aged 65 and older, and teens and adults aged 12 to 64 with health conditions that raise their risk for severe COVID, will receive a single shot. Researchers will check how well the vaccine boosts immunity and monitor safety for 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number US047
Austin, Texas, 78705-3298, United States
-
Investigational Site Number US073
Tomball, Texas, 77375, United States
-
Investigational Site Number US294
Lafayette, Louisiana, 70508, United States
-
Investigational Site Number US326
Omaha, Nebraska, 68134, United States
-
Investigational Site Number US381
Cincinnati, Ohio, 45246-2316, United States
-
Investigational Site Number US391
Pleasant View, Utah, 84404-4791, United States
-
Investigational Site Number US395
Melrose Park, Illinois, 60160, United States
-
Investigational Site Number US404
Phoenix, Arizona, 85044, United States
-
Investigational Site Number US406
Lenexa, Kansas, 66219, United States
-
Investigational Site Number US407
Southfield, Michigan, 48076-5412, United States
Conditions
Explore the condition pages connected to this study.